On the public citation graph

A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1

https://doi.org/10.1089/08892220152741450

0 signed · 526 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.1994.03520060067034openalex-snapshot

Features of HIV-1 That Could Influence Maternal-Child Transmission

inferredcites →https://doi.org/10.1001/jama.279.24.1984openalex-snapshot

Antiretroviral Drug Resistance Testing in Adults With HIV Infection

inferredcites →https://doi.org/10.1001/jama.283.3.381openalex-snapshot

Antiretroviral Therapy in Adults

inferredcites →https://doi.org/10.1002/(sici)1097-0290(20000105)67:1<97::aid-bit11>3.0.co;2-2openalex-snapshot

Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells

inferredcites →https://doi.org/10.1007/978-1-4684-6000-1_8openalex-snapshot

Common Sequence in HIV-1 GP41 and HLA Class II Beta Chains can Generate Crossreactive Autoantibodies with Immunosuppressive Potential Early in the Course of HIV-1 Infection

inferredcites →https://doi.org/10.1016/0065-2571(84)90007-4openalex-snapshot

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

inferredcites →https://doi.org/10.1016/s0022-1759(98)00107-0openalex-snapshot

A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples

inferredcites →https://doi.org/10.1016/s0952-7915(02)00362-xopenalex-snapshot

Neutralizing antibodies against HIV – back in the major leagues?

inferredcites →https://doi.org/10.1016/s0958-1669(02)00381-6openalex-snapshot

Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART

inferredcites →https://doi.org/10.1038/31405openalex-snapshot

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

inferredcites →https://doi.org/10.1038/3293openalex-snapshot

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

inferredcites →https://doi.org/10.1038/72309openalex-snapshot

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection

inferredcites →https://doi.org/10.1038/72318openalex-snapshot

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

inferredcites →https://doi.org/10.1038/nsb1295-1075openalex-snapshot

A trimeric structural domain of the HIV-1 transmembrane glycoprotein

inferredcites →https://doi.org/10.1073/pnas.87.8.3185openalex-snapshot

Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.

inferredcites →https://doi.org/10.1086/314773openalex-snapshot

A Longitudinal Study of Neutralizing Antibodies and Disease Progression in HIV‐1–Infected Subjects

inferredcites →https://doi.org/10.1086/315698openalex-snapshot

Single‐Dose Safety, Pharmacology, and Antiviral Activity of the Human Immunodeficiency Virus (HIV) Type 1 Entry Inhibitor PRO 542 in HIV‐Infected Adults

inferredcites →https://doi.org/10.1086/516443openalex-snapshot

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

inferredcites →https://doi.org/10.1086/516508openalex-snapshot

Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 in Primary Infection and Long‐Term‐Nonprogressive Infection

inferredcites →https://doi.org/10.1089/aid.1994.10.1651openalex-snapshot

A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1

inferredcites →https://doi.org/10.1089/aid.1994.10.359openalex-snapshot

Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization

inferredcites →https://doi.org/10.1093/infdis/165.2.364openalex-snapshot

Passive Immunotherapy in AIDS: A Randomized Trial of Serial Human Immunodeficiency Virus-Positive Transfusions of Plasma Rich in p24 Antibodies versus Transfusions of Seronegative Plasma

inferredcites →https://doi.org/10.1093/infdis/167.3.538openalex-snapshot

Human Immunodeficiency Virus (HIV) Type 1 Strain MN Neutralizing Antibody in HIV-Infected Children: Correlation with Clinical Status and Prognostic Value

inferredcites →https://doi.org/10.1093/infdis/168.2.298openalex-snapshot

Passive Immunotherapy in the Treatment of Advanced Human Immunodeficiency Virus Infection

inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a118408openalex-snapshot

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12

inferredcites →https://doi.org/10.1097/00002030-199402000-00004openalex-snapshot

Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays

inferredcites →https://doi.org/10.1097/00002030-199813000-00005openalex-snapshot

Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection

inferredcites →https://doi.org/10.1097/00002030-200203080-00020openalex-snapshot

Anti-idiotypic antibody Ab2/3H6 mimics the epitope of the neutralizing anti-HIV-1 monoclonal antibody 2F5

inferredcites →https://doi.org/10.1097/00002030-200210180-00006openalex-snapshot

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans

inferredcites →https://doi.org/10.1111/j.1600-0897.1997.tb00298.xopenalex-snapshot

The Role of Virologic and Immunologic Factors in Mother‐to‐Child Transmission of HIV‐1

inferredcites →https://doi.org/10.1126/science.7973652openalex-snapshot

Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody

inferredcites →https://doi.org/10.1128/jvi.65.9.4832-4838.1991openalex-snapshot

Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies

inferredcites →https://doi.org/10.1128/jvi.67.11.6642-6647.1993openalex-snapshot

A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1

inferredcites →https://doi.org/10.1128/jvi.69.11.6609-6617.1995openalex-snapshot

Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG

inferredcites →https://doi.org/10.1128/jvi.70.10.6751-6758.1996openalex-snapshot

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate

inferredcites →https://doi.org/10.1128/jvi.70.2.1100-1108.1996openalex-snapshot

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

inferredcites →https://doi.org/10.1128/jvi.73.5.4009-4018.1999openalex-snapshot

Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

inferredcites →https://doi.org/10.1128/jvi.75.22.10892-10905.2001openalex-snapshot

Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3416843openalex-extracted

Structural Basis for Broad HIV-1 Neutralization by a Novel MPER-Specific Human Broadly Neutralizing Antibody

inferred← citeshttps://doi.org/10.1002/1873-3468.14814openalex-snapshot

A two‐step mechanism for the binding of the HIV ‐1 MPER epitope by the 10 E 8 antibody onto biosensor‐supported lipid bilayers

inferred← citeshttps://doi.org/10.1002/9781118023648.ch6openalex-snapshot

Designing Immunogens for Vaccine Development in Reference to HIV

inferred← citeshttps://doi.org/10.1002/9783527669417.ch15openalex-snapshot

A Modern Biopharmaceutical to Treat AIDS – Challenges in Designing HIV Env Immunogens for Developing a Vaccine

inferred← citeshttps://doi.org/10.1002/advs.202003468openalex-snapshot

Cholesterol in the Viral Membrane is a Molecular Switch Governing HIV‐1 Env Clustering

inferred← citeshttps://doi.org/10.1002/ange.201903093openalex-snapshot

Unidirectional Presentation of Membrane Proteins in Nanoparticle‐Supported Liposomes

inferred← citeshttps://doi.org/10.1002/ange.202008804openalex-snapshot

Concentration‐Dependent Structural Transition of the HIV‐1 gp41 MPER Peptide into α‐Helical Trimers

inferred← citeshttps://doi.org/10.1002/anie.201903093openalex-snapshot

Unidirectional Presentation of Membrane Proteins in Nanoparticle‐Supported Liposomes

inferred← citeshttps://doi.org/10.1002/anie.202008804openalex-snapshot

Concentration‐Dependent Structural Transition of the HIV‐1 gp41 MPER Peptide into α‐Helical Trimers

inferred← citeshttps://doi.org/10.1002/biot.201500255openalex-snapshot

Overcoming low yields of plant‐made antibodies by a protein engineering approach

inferred← citeshttps://doi.org/10.1002/cbic.200800609openalex-snapshot

Interactions of HIV‐1 Antibodies 2F5 and 4E10 with a gp41 Epitope Prebound to Host and Viral Membrane Model Systems

inferred← citeshttps://doi.org/10.1002/cbic.201200493openalex-snapshot

Two Synthetic Antibodies that Recognize and Neutralize Distinct Proteolytic Forms of the Ebola Virus Envelope Glycoprotein

inferred← citeshttps://doi.org/10.1002/ejoc.201100296openalex-snapshot

Carbohydrates and Immunology: Synthetic Oligosaccharide Antigens for Vaccine Formulation

inferred← citeshttps://doi.org/10.1002/jmr.1116openalex-snapshot

Limitations to the structure‐based design of HIV‐1 vaccine immunogens

inferred← citeshttps://doi.org/10.1002/jmr.954openalex-snapshot

Combinatorial de novo design and application of a biomimetic affinity ligand for the purification of human anti‐HIV mAb 4E10 from transgenic tobacco

inferred← citeshttps://doi.org/10.1002/jmv.28005openalex-snapshot

Cell‐to‐cell transmission of HIV‐1 from provirus‐activated cells to resting naïve and memory human primary CD4 T cells is highly efficient and requires CD4 and F‐actin but not chemokine receptors

inferred← citeshttps://doi.org/10.1002/pro.2750openalex-snapshot

Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus‐1 gp41 and equine infectious anemia virus gp45

inferred← citeshttps://doi.org/10.1002/psc.2526openalex-snapshot

Multiple antigen peptide mimetics containing gp41 membrane‐proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs

inferred← citeshttps://doi.org/10.1007/1-4020-3103-3_4openalex-snapshot

Roles for Glycosylation in Receptor-Ligand Interactions in the Immune System

inferred← citeshttps://doi.org/10.1007/82_2020_221openalex-snapshot

Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design

inferred← citeshttps://doi.org/10.1007/978-1-4020-8811-7_9openalex-snapshot

Characterization of Immune Responses to Pathogen Challenge by Ms-Based Epitope Mapping

inferred← citeshttps://doi.org/10.1007/978-1-4614-7651-1_7openalex-snapshot

Cellular Entry of Retroviruses

inferred← citeshttps://doi.org/10.1007/978-1-4615-0065-0_13openalex-snapshot

The Carbohydrate Epitope of the Neutralizing Anti-HIV-1 Antibody 2G12

inferred← citeshttps://doi.org/10.1007/978-3-030-32459-9_12openalex-snapshot

Limitations to the Structure-Based Design of HIV-1 Vaccine Immunogens

inferred← citeshttps://doi.org/10.1007/978-3-540-72146-8_2openalex-snapshot

Antibodies for HIV Treatment and Prevention: Window of Opportunity?

inferred← citeshttps://doi.org/10.1007/978-981-13-0484-2_4openalex-snapshot

Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine

inferred← citeshttps://doi.org/10.1007/s00018-012-0972-yopenalex-snapshot

Immunological memory ≠ protective immunity

inferred← citeshttps://doi.org/10.1007/s00705-015-2710-xopenalex-snapshot

Study of antibody repertoires to the CD4 binding site of gp120 of a Chinese HIV-1-infected elite neutralizer, using 454 sequencing and single-cell sorting

inferred← citeshttps://doi.org/10.1007/s00705-018-4011-7openalex-snapshot

Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1007/s11904-016-0299-7openalex-snapshot

Broadly Neutralizing Antibodies for HIV Eradication

inferred← citeshttps://doi.org/10.1007/s12250-007-0047-7openalex-snapshot

“Unconventional” neutralizing activity of antibodies against HIV

inferred← citeshttps://doi.org/10.1007/s12250-013-3313-xopenalex-snapshot

Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1

inferred← citeshttps://doi.org/10.1007/s12250-015-3664-6openalex-snapshot

N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies

inferred← citeshttps://doi.org/10.1007/s13238-012-2111-9openalex-snapshot

Closing the door to human immunodeficiency virus

inferred← citeshttps://doi.org/10.1007/s13238-018-0534-7openalex-snapshot

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects

inferred← citeshttps://doi.org/10.1016/b978-0-12-396548-6.00002-0openalex-snapshot

Structure-Based Design for High-Hanging Vaccine Fruits

inferred← citeshttps://doi.org/10.1016/b978-0-12-397933-9.00024-2openalex-snapshot

The Cellular and Molecular Biology of HIV-1 Broadly Neutralizing Antibodies

inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00029-8openalex-snapshot

Human Immunodeficiency Virus Vaccines

inferred← citeshttps://doi.org/10.1016/b978-1-4160-3611-1.50054-4openalex-snapshot

Human immunodeficiency virus vaccines

inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00054-9openalex-snapshot

Human immunodeficiency virus vaccines

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00123-5openalex-snapshot

The Immunology of Human Immunodeficiency Virus Infection

inferred← citeshttps://doi.org/10.1016/bs.ai.2015.09.004openalex-snapshot

Evolution of the Humoral Response during HCV Infection

inferred← citeshttps://doi.org/10.1016/bs.apcsb.2015.03.002openalex-snapshot

The Use of Liposomes to Shape Epitope Structure and Modulate Immunogenic Responses of Peptide Vaccines Against HIV MPER

inferred← citeshttps://doi.org/10.1016/j.addr.2016.01.015openalex-snapshot

Microbicide vaginal rings: Technological challenges and clinical development

inferred← citeshttps://doi.org/10.1016/j.antiviral.2003.09.009openalex-snapshot

Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades

inferred← citeshttps://doi.org/10.1016/j.antiviral.2006.10.013openalex-snapshot

Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients

inferred← citeshttps://doi.org/10.1016/j.antiviral.2013.09.009openalex-snapshot

Construction and characterisation of replicating foamy viral vectors expressing HIV-1 epitopes recognised by broadly neutralising antibodies

inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.02.006openalex-snapshot

Reconstitution and characterization of antibody repertoires of HIV-1-infected “elite neutralizers”

inferred← citeshttps://doi.org/10.1016/j.bbamem.2007.12.018openalex-snapshot

Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission

inferred← citeshttps://doi.org/10.1016/j.bbamem.2018.02.019openalex-snapshot

Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds

inferred← citeshttps://doi.org/10.1016/j.bbapap.2014.05.010openalex-snapshot

Immunogen design for HIV-1 and influenza

inferred← citeshttps://doi.org/10.1016/j.bbrc.2008.08.105openalex-snapshot

Deletion of fusion peptide or destabilization of fusion core of HIV gp41 enhances antigenicity and immunogenicity of 4E10 epitope

inferred← citeshttps://doi.org/10.1016/j.bmc.2004.04.008openalex-snapshot

Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178

inferred← citeshttps://doi.org/10.1016/j.ceca.2007.04.011openalex-snapshot

The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent

inferred← citeshttps://doi.org/10.1016/j.cell.2016.05.024openalex-snapshot

Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity

inferred← citeshttps://doi.org/10.1016/j.cell.2019.11.003openalex-snapshot

High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

inferred← citeshttps://doi.org/10.1016/j.cell.2024.04.033openalex-snapshot

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans

inferred← citeshttps://doi.org/10.1016/j.celrep.2020.107583openalex-snapshot

HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies

inferred← citeshttps://doi.org/10.1016/j.celrep.2020.108037openalex-snapshot

Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments

inferred← citeshttps://doi.org/10.1016/j.celrep.2022.111624openalex-snapshot

HIV-1 Vpu restricts Fc-mediated effector functions in vivo

inferred← citeshttps://doi.org/10.1016/j.celrep.2024.115010openalex-snapshot

A multidonor class of highly glycan-dependent HIV-1 gp120-gp41 interface-targeting broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.chembiol.2003.12.020openalex-snapshot

Binding of High-Mannose-Type Oligosaccharides and Synthetic Oligomannose Clusters to Human Antibody 2G12

inferred← citeshttps://doi.org/10.1016/j.chom.2019.09.016openalex-snapshot

Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01

inferred← citeshttps://doi.org/10.1016/j.coi.2011.04.003openalex-snapshot

Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.coi.2015.05.007openalex-snapshot

New approaches to HIV vaccine development

inferred← citeshttps://doi.org/10.1016/j.coi.2016.05.013openalex-snapshot

Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.comptc.2011.07.024openalex-snapshot

Comparative structural studies of T-20 analogues using molecular dynamics

inferred← citeshttps://doi.org/10.1016/j.crviro.2020.100002openalex-snapshot

Proteasomal degradation of human SERINC4: A potent host anti-HIV-1 factor that is antagonized by nef

inferred← citeshttps://doi.org/10.1016/j.drudis.2011.08.013openalex-snapshot

HIV vaccine: hopes and hurdles

inferred← citeshttps://doi.org/10.1016/j.febslet.2013.10.014openalex-snapshot

Protein engineering strategies for the development of viral vaccines and immunotherapeutics

inferred← citeshttps://doi.org/10.1016/j.gene.2024.148607openalex-snapshot

Emerging trends and therapeutic applications of monoclonal antibodies

inferred← citeshttps://doi.org/10.1016/j.imbio.2005.05.025openalex-snapshot

Neutralization of HIV-1 primary isolate by ELDKWA-specific murine monoclonal antibodies

inferred← citeshttps://doi.org/10.1016/j.immuni.2004.12.011openalex-snapshot

Broadly Neutralizing Anti-HIV Antibody 4E10 Recognizes a Helical Conformation of a Highly Conserved Fusion-Associated Motif in gp41

inferred← citeshttps://doi.org/10.1016/j.immuni.2011.01.015openalex-snapshot

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

inferred← citeshttps://doi.org/10.1016/j.immuni.2012.08.012openalex-snapshot

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies

inferred← citeshttps://doi.org/10.1016/j.isci.2021.102987openalex-snapshot

Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile

inferred← citeshttps://doi.org/10.1016/j.isci.2022.105473openalex-snapshot

Adjuvants influence the maturation of VRC01-like antibodies during immunization

inferred← citeshttps://doi.org/10.1016/j.it.2006.06.007openalex-snapshot

Why do B cells mutate their immunoglobulin receptors?

inferred← citeshttps://doi.org/10.1016/j.it.2016.01.007openalex-snapshot

HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies

inferred← citeshttps://doi.org/10.1016/j.jim.2003.07.003openalex-snapshot

Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library

inferred← citeshttps://doi.org/10.1016/j.jim.2006.09.016openalex-snapshot

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning

inferred← citeshttps://doi.org/10.1016/j.jmb.2008.09.024openalex-snapshot

Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site

inferred← citeshttps://doi.org/10.1016/j.jmb.2011.10.014openalex-snapshot

Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope

inferred← citeshttps://doi.org/10.1016/j.jviromet.2015.09.011openalex-snapshot

Assembly and characterization of gp160-nanodiscs: A new platform for biochemical characterization of HIV envelope spikes

inferred← citeshttps://doi.org/10.1016/j.micinf.2008.12.008openalex-snapshot

Phenotypic studies on recombinant human immunodeficiency virus type 1 (HIV-1) containing CRF01_AE env gene derived from HIV-1-infected patient, residing in central Thailand

inferred← citeshttps://doi.org/10.1016/j.micinf.2013.10.015openalex-snapshot

Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals

inferred← citeshttps://doi.org/10.1016/j.molmed.2003.09.001openalex-snapshot

Immunofocusing: antigen engineering to promote the induction of HIV-neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.str.2010.06.010openalex-snapshot

Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope

inferred← citeshttps://doi.org/10.1016/j.tibtech.2004.07.012openalex-snapshot

Sugar-mediated ligand–receptor interactions in the immune system

inferred← citeshttps://doi.org/10.1016/j.tim.2012.08.011openalex-snapshot

HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design

inferred← citeshttps://doi.org/10.1016/j.vaccine.2005.01.099openalex-snapshot

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate

inferred← citeshttps://doi.org/10.1016/j.vaccine.2005.08.006openalex-snapshot

Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment

inferred← citeshttps://doi.org/10.1016/j.vaccine.2005.11.063openalex-snapshot

DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2006.09.071openalex-snapshot

Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state

inferred← citeshttps://doi.org/10.1016/j.vaccine.2008.11.050openalex-snapshot

Complement and antibodies: A dangerous liaison in HIV infection?

inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.08.009openalex-snapshot

Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen

inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.05.005openalex-snapshot

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.06.085openalex-snapshot

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review

inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.01.026openalex-snapshot

Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice

inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.06.074openalex-snapshot

Live attenuated rubella viral vectors stably express HIV and SIV vaccine antigens while reaching high titers

inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.02.055openalex-snapshot

Enhanced expression of HIV and SIV vaccine antigens in the structural gene region of live attenuated rubella viral vectors and their incorporation into virions

inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.12.045openalex-snapshot

Liposomal vaccines incorporating molecular adjuvants and intrastructural T-cell help promote the immunogenicity of HIV membrane-proximal external region peptides

inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.03.062openalex-snapshot

Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits

inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.03.039openalex-snapshot

Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region

inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.07.010openalex-snapshot

Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost

inferred← citeshttps://doi.org/10.1016/j.virol.2005.08.030openalex-snapshot

Genetic analysis of heptad-repeat regions in the G2 fusion subunit of the Junín arenavirus envelope glycoprotein

inferred← citeshttps://doi.org/10.1016/j.virol.2005.11.019openalex-snapshot

Neutralization and infectivity characteristics of envelope glycoproteins from human immunodeficiency virus type 1 infected donors whose sera exhibit broadly cross-reactive neutralizing activity

inferred← citeshttps://doi.org/10.1016/j.virol.2006.04.012openalex-snapshot

Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein

inferred← citeshttps://doi.org/10.1016/j.virol.2006.07.056openalex-snapshot

Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques

inferred← citeshttps://doi.org/10.1016/j.virol.2006.10.027openalex-snapshot

Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12

inferred← citeshttps://doi.org/10.1016/j.virol.2007.01.015openalex-snapshot

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies

inferred← citeshttps://doi.org/10.1016/j.virol.2007.05.024openalex-snapshot

Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens

inferred← citeshttps://doi.org/10.1016/j.virol.2007.10.018openalex-snapshot

N-terminal substitutions in HIV-1 gp41 reduce the expression of non-trimeric envelope glycoproteins on the virus

inferred← citeshttps://doi.org/10.1016/j.virol.2007.11.005openalex-snapshot

Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles

inferred← citeshttps://doi.org/10.1016/j.virol.2007.11.009openalex-snapshot

Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope

inferred← citeshttps://doi.org/10.1016/j.virol.2008.04.005openalex-snapshot

Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics

inferred← citeshttps://doi.org/10.1016/j.virol.2009.05.015openalex-snapshot

Characterization of a trimeric MPER containing HIV-1 gp41 antigen

inferred← citeshttps://doi.org/10.1016/j.virol.2009.05.028openalex-snapshot

Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection

inferred← citeshttps://doi.org/10.1016/j.virol.2009.10.044openalex-snapshot

Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1

inferred← citeshttps://doi.org/10.1016/j.virol.2010.03.016openalex-snapshot

Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein

inferred← citeshttps://doi.org/10.1016/j.virol.2011.01.023openalex-snapshot

Immunological properties of the transmembrane envelope protein of the feline foamy virus and its use for serological screening

inferred← citeshttps://doi.org/10.1016/j.virol.2012.10.004openalex-snapshot

Broadly neutralizing antibodies against HIV-1: Templates for a vaccine

inferred← citeshttps://doi.org/10.1016/j.virol.2014.05.036openalex-snapshot

Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice

inferred← citeshttps://doi.org/10.1016/j.virol.2014.06.006openalex-snapshot

Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence

inferred← citeshttps://doi.org/10.1016/j.virol.2014.10.036openalex-snapshot

Sequence variation of koala retrovirus transmembrane protein p15E among koalas from different geographic regions

inferred← citeshttps://doi.org/10.1016/j.virol.2015.09.010openalex-snapshot

Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region

inferred← citeshttps://doi.org/10.1016/j.virol.2016.01.002openalex-snapshot

Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure

inferred← citeshttps://doi.org/10.1016/j.virol.2016.09.011openalex-snapshot

Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India

inferred← citeshttps://doi.org/10.1016/j.virol.2017.02.015openalex-snapshot

Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region

inferred← citeshttps://doi.org/10.1016/j.virusres.2010.04.006openalex-snapshot

Characterization of a SHIV162P3 variant evolved in an infected rhesus macaque with persistent plasma viremia

inferred← citeshttps://doi.org/10.1016/j.virusres.2019.197763openalex-snapshot

Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8

inferred← citeshttps://doi.org/10.1016/s0264-410x(02)00389-4openalex-snapshot

Do not underestimate the power of antibodies—lessons from adoptive transfer of antibodies against HIV

inferred← citeshttps://doi.org/10.1016/s0952-7915(02)00362-xopenalex-snapshot

Neutralizing antibodies against HIV – back in the major leagues?

inferred← citeshttps://doi.org/10.1016/s0958-1669(02)00381-6openalex-snapshot

Anti-R7V antibodies as therapeutics for HIV-infected patients in failure of HAART

inferred← citeshttps://doi.org/10.1016/s1007-0214(05)70109-7openalex-snapshot

Monoclonal antibodies recognizing HIV-1 gp41 could inhibit env-mediated syncytium formation

inferred← citeshttps://doi.org/10.1016/s1054-3589(07)55002-7openalex-snapshot

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors

inferred← citeshttps://doi.org/10.1016/s1054-3589(07)56003-5openalex-snapshot

HIV‐1‐Specific Immune Response

inferred← citeshttps://doi.org/10.1016/s1473-3099(10)70069-4openalex-snapshot

Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference

inferred← citeshttps://doi.org/10.1021/acsinfecdis.0c00243openalex-snapshot

Cholesterol Constrains the Antigenic Configuration of the Membrane-Proximal Neutralizing HIV-1 Epitope

inferred← citeshttps://doi.org/10.1021/bi0612521openalex-snapshot

Structural Analysis and Assembly of the HIV-1 Gp41 Amino-Terminal Fusion Peptide and the Pretransmembrane Amphipathic-At-Interface Sequence

inferred← citeshttps://doi.org/10.1021/bi3016668openalex-snapshot

Anti-Idiotypic Monobodies Derived from a Fibronectin Scaffold

inferred← citeshttps://doi.org/10.1021/bi501171ropenalex-snapshot

The Membrane Proximal External Regions of gp41 from HIV-1 Strains HXB2 and JRFL Have Different Sensitivities to Alanine Mutation

inferred← citeshttps://doi.org/10.1021/bk-2006-0932.ch006openalex-snapshot

Carbohydrate-Based Vaccines against HIV/AIDS

inferred← citeshttps://doi.org/10.1021/bk-2012-1102.ch006openalex-snapshot

Carbohydrate-Based Vaccines against HIV/AIDS

inferred← citeshttps://doi.org/10.1038/cmi.2010.8openalex-snapshot

The good and evil of complement activation in HIV-1 infection

inferred← citeshttps://doi.org/10.1038/nature05818openalex-snapshot

Exploiting the defensive sugars of HIV-1 for drug and vaccine design

inferred← citeshttps://doi.org/10.1038/nature10373openalex-snapshot

Broad neutralization coverage of HIV by multiple highly potent antibodies

inferred← citeshttps://doi.org/10.1038/nchembio.1685openalex-snapshot

Recent strategies targeting HIV glycans in vaccine design

inferred← citeshttps://doi.org/10.1038/ncomms1100openalex-snapshot

B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection

inferred← citeshttps://doi.org/10.1038/nm1244openalex-snapshot

Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies

inferred← citeshttps://doi.org/10.1038/nrmicro1819openalex-snapshot

The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus

inferred← citeshttps://doi.org/10.1038/nsmb.1944openalex-snapshot

Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region

inferred← citeshttps://doi.org/10.1038/nsmb.1950openalex-snapshot

Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies

inferred← citeshttps://doi.org/10.1038/nsmb.2922openalex-snapshot

Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1038/s41401-025-01535-5openalex-snapshot

The conformational epitope of a gp41-specific mucosal protective IgA binds to the HIV-1 envelope and neutralizes infection

inferred← citeshttps://doi.org/10.1038/s41426-018-0087-0openalex-snapshot

Comparison of the genotypic and phenotypic properties of HIV-1 standard subtype B and subtype B/B’ env molecular clones derived from infections in China

inferred← citeshttps://doi.org/10.1038/s41467-023-42098-5openalex-snapshot

Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site

inferred← citeshttps://doi.org/10.1038/s41589-020-0496-yopenalex-snapshot

HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes

inferred← citeshttps://doi.org/10.1038/s41591-018-0042-6openalex-snapshot

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

inferred← citeshttps://doi.org/10.1038/s41598-020-79327-6openalex-snapshot

Structure, membrane topology and influence of cholesterol of the membrane proximal region: transmembrane helical anchor sequence of gp41 from HIV

inferred← citeshttps://doi.org/10.1038/s42003-022-04219-6openalex-snapshot

Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope

inferred← citeshttps://doi.org/10.1038/scibx.2008.2openalex-snapshot

Simply irresistible?

inferred← citeshttps://doi.org/10.1038/srep45163openalex-snapshot

Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library

inferred← citeshttps://doi.org/10.1039/b419015gopenalex-snapshot

Synthesis of constrained helical peptides by thioether ligation: application to analogs of gp41

inferred← citeshttps://doi.org/10.1051/jbio/2015019openalex-snapshot

Vers un vaccin contre le VIH : des anticorps induits par un peptide de la gp41 neutralisent le virus et inhibent sa pathogénèse

inferred← citeshttps://doi.org/10.1073/pnas.0505126102openalex-snapshot

Antibody vs. HIV in a clash of evolutionary titans

inferred← citeshttps://doi.org/10.1073/pnas.0901474106openalex-snapshot

Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

inferred← citeshttps://doi.org/10.1073/pnas.0908713106openalex-snapshot

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

inferred← citeshttps://doi.org/10.1073/pnas.1004600107openalex-snapshot

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

inferred← citeshttps://doi.org/10.1073/pnas.1012923107openalex-snapshot

Scaffolding to build a rational vaccine design strategy

inferred← citeshttps://doi.org/10.1073/pnas.1204533109openalex-snapshot

HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120

inferred← citeshttps://doi.org/10.1073/pnas.1309842111openalex-snapshot

Structure of an HIV-1–neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer

inferred← citeshttps://doi.org/10.1073/pnas.1807259115openalex-snapshot

Structure of the membrane proximal external region of HIV-1 envelope glycoprotein

inferred← citeshttps://doi.org/10.1073/pnas.2112887119openalex-snapshot

Engineering pan–HIV-1 neutralization potency through multispecific antibody avidity

inferred← citeshttps://doi.org/10.1074/jbc.m110.111351openalex-snapshot

Structural Characterization of HIV gp41 with the Membrane-proximal External Region

inferred← citeshttps://doi.org/10.1074/jbc.m110.116699openalex-snapshot

Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1

inferred← citeshttps://doi.org/10.1074/jbc.m110.156588openalex-snapshot

Stabilized HIV-1 Envelope Glycoprotein Trimers Lacking the V1V2 Domain, Obtained by Virus Evolution

inferred← citeshttps://doi.org/10.1074/jbc.m111.224527openalex-snapshot

Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China

inferred← citeshttps://doi.org/10.1074/jbc.m111.319863openalex-snapshot

A Monoclonal Antibody Directed against a Conformational Epitope of the HIV-1 Trans-activator (Tat) Protein Neutralizes Cross-clade

inferred← citeshttps://doi.org/10.1074/jbc.m114.569566openalex-snapshot

A Fusion Intermediate gp41 Immunogen Elicits Neutralizing Antibodies to HIV-1

inferred← citeshttps://doi.org/10.1074/jbc.m114.621185openalex-snapshot

Antigenicity and Immunogenicity of a Trimeric Envelope Protein from an Indian Clade C HIV-1 Isolate

inferred← citeshttps://doi.org/10.1074/jbc.m117.777714openalex-snapshot

SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins

inferred← citeshttps://doi.org/10.1074/jbc.m411088200openalex-snapshot

Trimeric Membrane-anchored gp41 Inhibits HIV Membrane Fusion

inferred← citeshttps://doi.org/10.1074/jbc.m412770200openalex-snapshot

Steric Accessibility of the HIV-1 gp41 N-trimer Region

inferred← citeshttps://doi.org/10.1074/jbc.m414515200openalex-snapshot

Design, Expression, and Immunogenicity of a Soluble HIV Trimeric Envelope Fragment Adopting a Prefusion gp41 Configuration

inferred← citeshttps://doi.org/10.1074/jbc.m605998200openalex-snapshot

Recognition and Blocking of HIV-1 gp41 Pre-transmembrane Sequence by Monoclonal 4E10 Antibody in a Raft-like Membrane Environment

inferred← citeshttps://doi.org/10.1074/jbc.ra119.009481openalex-snapshot

The lipid membrane of HIV-1 stabilizes the viral envelope glycoproteins and modulates their sensitivity to antibody neutralization

inferred← citeshttps://doi.org/10.1080/08982100701530159openalex-snapshot

One Step Membrane Incorporation of Viral Antigens as a Vaccine Candidate Against HIV

inferred← citeshttps://doi.org/10.1080/09205063.2014.940243openalex-snapshot

Carbohydrate-functionalized nanovaccines preserve HIV-1 antigen stability and activate antigen presenting cells

inferred← citeshttps://doi.org/10.1080/13543776.2018.1495708openalex-snapshot

HIV cure: global overview of bNAbs’ patents and related scientific publications

inferred← citeshttps://doi.org/10.1080/14760584.2019.1690458openalex-snapshot

Strategies for inducing effective neutralizing antibody responses against HIV-1

inferred← citeshttps://doi.org/10.1080/19420862.2016.1170263openalex-snapshot

A novel antibody discovery platform identifies anti-influenza A broadly neutralizing antibodies from human memory B cells

inferred← citeshttps://doi.org/10.1084/jem.20051639openalex-snapshot

Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

inferred← citeshttps://doi.org/10.1084/jem.20091281openalex-snapshot

Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines

inferred← citeshttps://doi.org/10.1084/jem.20101907openalex-snapshot

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

inferred← citeshttps://doi.org/10.1084/jem.20121827openalex-snapshot

Neutralizing antibodies to HIV-1 induced by immunization

inferred← citeshttps://doi.org/10.1084/jem.20121977openalex-snapshot

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies

inferred← citeshttps://doi.org/10.1084/jem.20161765openalex-snapshot

Progress toward active or passive HIV-1 vaccination

inferred← citeshttps://doi.org/10.1084/jem.20180246openalex-snapshot

Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity

inferred← citeshttps://doi.org/10.1086/380102openalex-snapshot

Potent Cross‐Group Neutralization of Primary Human Immunodeficiency Virus Isolates with Monoclonal Antibodies—Implications for Acquired Immunodeficiency Syndrome Vaccine

showing the first 200 of 488 · page through all 488

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.